Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study) (RELAX)

This study has been completed.

Sponsor:

Duke University

ClinicalTrials.gov Identifier:

NCT00763867

First Posted: October 1, 2008

Last Update Posted: July 23, 2014

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Explanation of how the number of participants for analysis was determined.
Includes whether analysis was per protocol, intention to treat, or another method.
Also provides relevant details such as imputation technique, as appropriate.

Explanation of how the number of participants for analysis was determined.
Includes whether analysis was per protocol, intention to treat, or another method.
Also provides relevant details such as imputation technique, as appropriate.

Participants analyzed consisted of those participants who had the endpoint data available to be derived.

Reporting Groups

Description

Placebo

placebo 20 mg three tid for 12 weeks followed by 60 mg tid for 12 weeks

Sildenafil

sildenafil 20 mg three tid for 12 weeks followed by 60 mg tid for 12 weeks